Novartis Bioventures Ltd Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Novartis Bioventures Ltd.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).

Latest Insider Trading Transactions of Novartis Bioventures Ltd

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd		Sell	S	8.25	1,001,312	8,260,824	2,467,961	3.5 M to 2.5 M (-28.86 %)
Jun 22 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd		Sell	S	9.04	900	8,136	3,469,273	3.5 M to 3.5 M (-0.03 %)
Jun 22 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd		Sell	S	8.25	1,001,312	8,260,824	2,467,961	3.5 M to 2.5 M (-28.86 %)
Jun 22 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd		Sell	S	9.04	900	8,136	3,469,273	3.5 M to 3.5 M (-0.03 %)
Jun 17 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.27	4,622	42,846	3,470,173	3.5 M to 3.5 M (-0.13 %)
Jun 17 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.30	8,600	79,980	3,474,795	3.5 M to 3.5 M (-0.25 %)
Jun 17 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.05	6,164	55,784	3,483,395	3.5 M to 3.5 M (-0.18 %)
Jun 12 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.19	1,500	13,785	3,489,559	3.5 M to 3.5 M (-0.04 %)
Jun 12 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.21	7,200	66,312	3,491,059	3.5 M to 3.5 M (-0.21 %)
Jun 12 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.46	8,532	80,713	3,498,259	3.5 M to 3.5 M (-0.24 %)
Jun 09 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.38	7,000	65,660	3,506,791	3.5 M to 3.5 M (-0.20 %)
Jun 09 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.66	5,659	54,666	3,513,791	3.5 M to 3.5 M (-0.16 %)
Jun 09 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.66	8,652	83,578	3,519,450	3.5 M to 3.5 M (-0.25 %)
Jun 04 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.55	4,088	39,040	3,528,102	3.5 M to 3.5 M (-0.12 %)
Jun 04 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.78	5,208	50,934	3,532,190	3.5 M to 3.5 M (-0.15 %)
Jun 04 2020	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Sell	S	9.68	5,669	54,876	3,537,398	3.5 M to 3.5 M (-0.16 %)
Nov 12 2019	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	451,609	0	0
Nov 12 2019	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	7,200,000	0	0
Nov 12 2019	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	9,000,000	0	0
Nov 12 2019	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Buy	P	12.00	250,000	3,000,000	3,543,067	3.3 M to 3.5 M (+7.59 %)
Nov 12 2019	GRTX	Galera Therapeutic ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	3,293,067	0	3,293,067	0 to 3.3 M
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	636,366	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	636,366	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	X	0.00	71,450	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	X	0.00	71,450	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	893,195	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	893,195	0	0
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	P	14.00	168,630	2,360,820	1,769,641	1.6 M to 1.8 M (+10.53 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	P	14.00	168,630	2,360,820	1,769,641	1.6 M to 1.8 M (+10.53 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	636,366	0	1,601,011	964.6 K to 1.6 M (+65.97 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	636,366	0	1,601,011	964.6 K to 1.6 M (+65.97 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	X	0.00	71,450	0	964,645	893.2 K to 964.6 K (+8.00 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	X	0.00	71,450	0	964,645	893.2 K to 964.6 K (+8.00 %)
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	893,195	0	893,195	0 to 893.2 K
May 30 2019	BCYC	BICYCLE THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	893,195	0	893,195	0 to 893.2 K
Apr 29 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.03	138,704	142,865	4,049,804	4.2 M to 4 M (-3.31 %)
Apr 29 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.03	563,096	579,989	4,188,508	4.8 M to 4.2 M (-11.85 %)
Apr 24 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.03	16,403	16,895	4,751,604	4.8 M to 4.8 M (-0.34 %)
Apr 24 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.03	27,554	28,381	4,768,007	4.8 M to 4.8 M (-0.57 %)
Apr 24 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.97	7,100	6,887	4,795,561	4.8 M to 4.8 M (-0.15 %)
Apr 15 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.99	28,794	28,506	4,802,661	4.8 M to 4.8 M (-0.60 %)
Apr 15 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.04	30,908	32,144	4,831,455	4.9 M to 4.8 M (-0.64 %)
Apr 15 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.08	57,438	62,033	4,862,363	4.9 M to 4.9 M (-1.17 %)
Apr 10 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.09	140,230	152,851	4,919,801	5.1 M to 4.9 M (-2.77 %)
Apr 10 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.01	32,991	33,321	5,060,031	5.1 M to 5.1 M (-0.65 %)
Apr 10 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.02	27,525	28,076	5,093,022	5.1 M to 5.1 M (-0.54 %)
Apr 05 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.02	24,661	25,154	5,120,547	5.1 M to 5.1 M (-0.48 %)
Apr 05 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.01	47,900	48,379	5,145,208	5.2 M to 5.1 M (-0.92 %)
Apr 05 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.96	58,033	55,712	5,193,108	5.3 M to 5.2 M (-1.11 %)
Apr 02 2019	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.90	20,610	39,159	2,079,394	2.1 M to 2.1 M (-0.98 %)
Apr 02 2019	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.85	106,540	197,099	2,100,004	2.2 M to 2.1 M (-4.83 %)
Apr 02 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.97	51,754	50,201	5,251,141	5.3 M to 5.3 M (-0.98 %)
Apr 02 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.95	116,909	111,064	5,302,895	5.4 M to 5.3 M (-2.16 %)
Apr 02 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.91	63,100	57,421	5,419,804	5.5 M to 5.4 M (-1.15 %)
Mar 28 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.94	88,835	83,505	5,482,904	5.6 M to 5.5 M (-1.59 %)
Mar 28 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	0.99	50,749	50,242	5,571,739	5.6 M to 5.6 M (-0.90 %)
Mar 28 2019	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.01	177,762	179,540	5,622,488	5.8 M to 5.6 M (-3.06 %)
Mar 15 2019	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.92	43,800	84,096	2,206,544	2.3 M to 2.2 M (-1.95 %)
Mar 15 2019	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	1.88	13,800	25,944	2,250,344	2.3 M to 2.3 M (-0.61 %)
Mar 15 2019	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.12	132,738	281,405	2,264,144	2.4 M to 2.3 M (-5.54 %)
Sep 14 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	465,086	1,241,780	0
Sep 14 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	2,069,993	0	8,345,145	6.3 M to 8.3 M (+32.99 %)
Aug 22 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.30	20,388	46,892	2,396,882	2.4 M to 2.4 M (-0.84 %)
Aug 22 2018	ARPO	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.90	5,300	20,670	5,800,250	5.8 M to 5.8 M (-0.09 %)
Aug 20 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.10	8,700	18,270	2,417,270	2.4 M to 2.4 M (-0.36 %)
Aug 20 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.10	8,808	18,497	2,425,970	2.4 M to 2.4 M (-0.36 %)
Aug 16 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.15	2,635	5,665	2,434,778	2.4 M to 2.4 M (-0.11 %)
Aug 16 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.26	3,300	7,458	2,437,413	2.4 M to 2.4 M (-0.14 %)
Aug 14 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.36	1,600	3,776	2,440,713	2.4 M to 2.4 M (-0.07 %)
Aug 14 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.44	5,615	13,701	2,442,313	2.4 M to 2.4 M (-0.23 %)
Aug 10 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.48	235	583	2,447,928	2.4 M to 2.4 M (-0.01 %)
Aug 10 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.78	1,000	2,780	2,448,163	2.4 M to 2.4 M (-0.04 %)
Aug 08 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	2.97	1,739	5,165	2,449,163	2.5 M to 2.4 M (-0.07 %)
Aug 08 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.02	2,942	8,885	2,450,902	2.5 M to 2.5 M (-0.12 %)
Aug 06 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.33	4,702	15,658	2,453,844	2.5 M to 2.5 M (-0.19 %)
Aug 02 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.22	8,181	26,343	2,458,546	2.5 M to 2.5 M (-0.33 %)
Aug 02 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.07	4,500	13,815	2,466,727	2.5 M to 2.5 M (-0.18 %)
Jul 31 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.27	2,000	6,540	2,471,227	2.5 M to 2.5 M (-0.08 %)
Jul 31 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.38	6,458	21,828	2,473,227	2.5 M to 2.5 M (-0.26 %)
Jul 27 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.63	7,937	28,811	2,479,685	2.5 M to 2.5 M (-0.32 %)
Jul 27 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	3.84	12,460	47,846	2,487,622	2.5 M to 2.5 M (-0.50 %)
Jul 25 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	4.11	700	2,877	2,500,082	2.5 M to 2.5 M (-0.03 %)
Jul 25 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	4.25	30,600	130,050	2,500,782	2.5 M to 2.5 M (-1.21 %)
Jul 18 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	4.71	12,500	58,875	2,531,382	2.5 M to 2.5 M (-0.49 %)
Jul 18 2018	ALRN	AILERON THERAPEUTI ...	Novartis Bioventures Ltd	10% Owner	Sell	S	5.15	300	1,545	2,543,882	2.5 M to 2.5 M (-0.01 %)
Jul 13 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	0
Jul 13 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	663,346	0	6,275,152	5.6 M to 6.3 M (+11.82 %)
Jun 19 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	14,449	0	5,611,806	5.6 M to 5.6 M (+0.26 %)
Jun 15 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	345
Jun 15 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	720,878	0	5,597,357	4.9 M to 5.6 M (+14.78 %)
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	690
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	767,728	0	4,876,479	4.1 M to 4.9 M (+18.69 %)
May 17 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	274,703	0	4,108,751	3.8 M to 4.1 M (+7.16 %)
May 14 2018	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd		Sell	S	10.06	19,550	196,673	2,175,314	2.2 M to 2.2 M (-0.89 %)
May 11 2018	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd		Sell	S	10.13	22,725	230,204	2,194,864	2.2 M to 2.2 M (-1.02 %)
May 11 2018	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd		Sell	S	10.11	51,230	517,935	2,217,589	2.3 M to 2.2 M (-2.26 %)
May 09 2018	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd		Sell	S	10.03	26,557	266,367	2,268,819	2.3 M to 2.3 M (-1.16 %)
May 09 2018	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd		Sell	S	10.11	15,548	157,190	2,295,376	2.3 M to 2.3 M (-0.67 %)
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,035
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	217,159	0	3,834,048	3.6 M to 3.8 M (+6.00 %)
Apr 18 2018	ALT	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	482,907	0	3,616,889	3.1 M to 3.6 M (+15.41 %)
Mar 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,380
Mar 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	261,969	0	3,133,982	2.9 M to 3.1 M (+9.12 %)
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	1,725
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	67,925	0	2,872,013	2.8 M to 2.9 M (+2.42 %)
Feb 15 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	269,527	0	2,804,088	2.5 M to 2.8 M (+10.63 %)
Jan 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,070
Jan 19 2018	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	176,586	0	2,534,561	2.4 M to 2.5 M (+7.49 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,415
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	65,718	0	2,357,975	2.3 M to 2.4 M (+2.87 %)
Dec 15 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	242,694	0	2,292,257	2 M to 2.3 M (+11.84 %)
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	J	2.67	345	921	2,760
Nov 16 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Buy	J	0.00	182,262	0	2,049,563	1.9 M to 2 M (+9.76 %)
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	465,086	1,241,780	465,086
Aug 23 2017	PIP	Altimmune, Inc.	Novartis Bioventures Ltd	10% Owner	Option Exercise	P	2.67	3,104	8,288	3,104
Jun 20 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.02	3,220	70,899	2,251,457	2.3 M to 2.3 M (-0.14 %)
Jun 20 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.24	53,200	1,130,207	2,254,677	2.3 M to 2.3 M (-2.31 %)
Jun 12 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.00	700	15,400	2,307,877	2.3 M to 2.3 M (-0.03 %)
Jun 08 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.11	4,840	106,999	2,308,577	2.3 M to 2.3 M (-0.21 %)
Jun 08 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.98	7,274	167,161	2,313,417	2.3 M to 2.3 M (-0.31 %)
Jun 06 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.11	4,780	110,488	2,320,691	2.3 M to 2.3 M (-0.21 %)
Jun 06 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.47	14,867	348,949	2,325,471	2.3 M to 2.3 M (-0.64 %)
Jun 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.89	10,722	256,176	2,340,338	2.4 M to 2.3 M (-0.46 %)
Jun 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.94	35,539	850,896	2,351,060	2.4 M to 2.4 M (-1.49 %)
May 25 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.01	17,451	436,364	2,391,952	2.4 M to 2.4 M (-0.72 %)
May 22 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.50	9,019	229,964	2,409,403	2.4 M to 2.4 M (-0.37 %)
May 18 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.51	22,534	574,901	2,418,422	2.4 M to 2.4 M (-0.92 %)
May 18 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	26.33	20,081	528,725	2,440,956	2.5 M to 2.4 M (-0.82 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.91	7,778	162,658	2,461,037	2.5 M to 2.5 M (-0.32 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.86	7,847	163,670	2,468,815	2.5 M to 2.5 M (-0.32 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.96	57,844	1,212,306	2,476,662	2.5 M to 2.5 M (-2.28 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.93	5,398	113,000	2,534,506	2.5 M to 2.5 M (-0.21 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.04	4,999	105,160	2,539,904	2.5 M to 2.5 M (-0.20 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.86	749	16,370	2,544,903	2.5 M to 2.5 M (-0.03 %)
Mar 17 2017	ZETAII	Aerpio Pharmaceuti ...	Novartis Bioventures Ltd	10% Owner	Buy	P	5.00	560,000	2,800,000	5,805,550	5.2 M to 5.8 M (+10.68 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	3,402,729	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	3,657,932	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	9,728,589	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	X	0.07	62,914	4,404	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	P	13.00	84,615	1,099,995	2,545,652	2.5 M to 2.5 M (+3.44 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	486,104	0	2,461,037	2 M to 2.5 M (+24.61 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	522,561	0	1,974,933	1.5 M to 2 M (+35.98 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	1,389,797	0	1,452,372	62.6 K to 1.5 M (+2,221.01 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	13.00	339	4,407	62,575	62.9 K to 62.6 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Buy	X	0.07	62,914	4,404	62,914	0 to 62.9 K
Feb 17 2016	PTI	PROTEOSTASIS THERA ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	1,944,315	0	0
Feb 17 2016	PTI	PROTEOSTASIS THERA ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	10,000,000	0	0
Feb 17 2016	PTI	PROTEOSTASIS THERA ...	Novartis Bioventures Ltd	10% Owner	Buy	P	8.00	375,000	3,000,000	1,873,791	1.5 M to 1.9 M (+25.02 %)
Feb 17 2016	PTI	PROTEOSTASIS THERA ...	Novartis Bioventures Ltd	10% Owner	Buy	C	0.00	1,498,791	0	1,498,791	0 to 1.5 M
Apr 12 2016	AGLE	Aeglea BioTherapeu ...	Novartis Bioventures Ltd	10% Owner	Option Exercise	C	0.00	1,120,448	0	0

Page: 1 2 next >